#5 - Alex Zhavoronkov - Artificial Intelligence and Drug/Biomarker Discovery: Why AI Will Play a Massive Role In Pushing BioTech Forward

Alex Zhavoronkov is a particularly high level human being, originally working in the field of computer science, Alex had a realization that contributing to aging and aging research would be the biggest contribution he could make for humanity. Utilizing his expertise in computer science and artificial intelligence, he began using these skills to enter the world of longevity in a significant way. Artificial intelligence will play a massive role in drug and biomarker discovery going forward and Alex's company, Insilico Medicine is leading the charge in a serious way.It was an absolute honor to speak with Alex Zhavoronkov as he explained in simple terms just how exciting Insilico's tech is. How it works, all the different projects they are involved in, and just how much of a financial behemoth Insilico has the potential to be. (Keep an eye out for their IPO in the next few years)-James Ruhle, SimpleBioTechPodcast.comStay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTechIf you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle